Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Sposto

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
Journal of Neuro-Oncology|November 5, 2018
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trialsDiana S Osorio, Neha Patel, Lingyun Ji, et al.
Plos One|May 26, 2017
Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell diseasePatjanaporn Chalacheva, Maha Khaleel, John Sunwoo, et al.
Pediatric Blood & Cancer|February 23, 2008
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocolsGirish Dhall, Howard Grodman, Lingyun Ji, et al.
Pediatric Blood & Cancer|September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastomaAlekist Quach, Lingyun Ji, Vikash Mishra, et al.
Pediatric Blood & Cancer|July 29, 2006
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescueStergios Zacharoulis, Adam Levy, Susan N Chi, et al.
Pediatric Blood & Cancer|September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology GroupJames H Garvin, Michael T Selch, Emi Holmes, et al.
Journal of Pediatric Hematology/Oncology|May 6, 2004
Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08Mark A Lones, Warren G Sanger, Michelle M Le Beau, et al.
American Journal of Hematology|September 18, 2020
Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidencePayal Shah, Silvie Suriany, Roberta Kato, et al.
Cancer Genetics and Cytogenetics|November 23, 2006
Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08Mark A Lones, Nyla A Heerema, Michelle M Le Beau, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
Journal of Neuro-Oncology|November 5, 2018
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trialsDiana S Osorio, Neha Patel, Lingyun Ji, et al.
Plos One|May 26, 2017
Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell diseasePatjanaporn Chalacheva, Maha Khaleel, John Sunwoo, et al.
Pediatric Blood & Cancer|February 23, 2008
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocolsGirish Dhall, Howard Grodman, Lingyun Ji, et al.
Pediatric Blood & Cancer|September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastomaAlekist Quach, Lingyun Ji, Vikash Mishra, et al.
Pediatric Blood & Cancer|July 29, 2006
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescueStergios Zacharoulis, Adam Levy, Susan N Chi, et al.
Pediatric Blood & Cancer|September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology GroupJames H Garvin, Michael T Selch, Emi Holmes, et al.
Journal of Pediatric Hematology/Oncology|May 6, 2004
Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08Mark A Lones, Warren G Sanger, Michelle M Le Beau, et al.
American Journal of Hematology|September 18, 2020
Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidencePayal Shah, Silvie Suriany, Roberta Kato, et al.
Cancer Genetics and Cytogenetics|November 23, 2006
Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08Mark A Lones, Nyla A Heerema, Michelle M Le Beau, et al.
Pageof 18